|Bid||2.6500 x 800|
|Ask||2.6900 x 1000|
|Day's range||2.5750 - 2.7100|
|52-week range||1.8300 - 8.7300|
|Beta (5Y monthly)||2.51|
|PE ratio (TTM)||N/A|
|Earnings date||15 Nov 2021 - 19 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||5.40|
Greenlane (GNLN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Greenlane (GNLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Greenlane Holdings, Inc. ("Greenlane") (Nasdaq: GNLN), and KushCo Holdings, Inc. (''KushCo'') (OTCQX: KSHB) today announced the expiration of the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") in connection with the previously announced proposed merger (the "Transaction"). The Transaction is expected to close in the third quarter of 2021, subject to the satisfaction or waiver of all remaining conditions in the agreement, including the receipt of all necessary approvals.